Pharmaceutical Companies of Johnson & Johnson

Advancing New Healthcare Solutions Through Collaboration

Learn About the Companys Rich Heritage at Our Digital Museum

This site is governed solely by applicable U.S. laws and governmental regulations. Please see ourPrivacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to ourPrivacy Policy. Your use of the information on this site is subject to the terms of ourLegal Notice. You should view theNewssection and the most recent SEC Filings in theInvestorsection in order to receive the most current information made available by Johnson & Johnson Services, ntact Uswith any questions or search this site for more information.

All contents © Copyright Johnson & Johnson Services, Inc.1997-2019. All Rights Reserved.

Johnson & Johnson to Host Investor Conference Call on Third Quarter Results

Johnson & Johnson to Host Investor Conference Call on Third Quarter Results

New Brunswick, NJ (September 18, 2019)- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15thto review third-quarter results. Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host the call. The question and answer portion of the call will also include the following executives: Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices; Thibaut Mongon, Executive Vice President, Worldwide Chairman, Consumer; and Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals.

Investors and other interested parties can access the webcast/conference call in the

The webcast and presentation material are accessible at Johnson & Johnsons website A replay of the webcast will be available approximately three hours after the conference call concludes.

By telephone: for both listen-only participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is . For participants outside the U.S., the dial-in number is .

A replay of the conference call will be available until approximately 12:00 a.m. on October 23, 2019. The replay dial-in number for U.S. participants is . For participants outside the U.S., the replay dial-in number is . The replay conference ID number for all callers is 13694535.

The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.

About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. Thats why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the worlds largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

This site uses cookies as described in ourCookie Policy. Please click the Accept button or continue to use our site if you agree to our use of cookies.

Pharmaceutical Companies of Johnson & Johnson

Advancing New Healthcare Solutions Through Collaboration

Learn About the Companys Rich Heritage at Our Digital Museum

This site is governed solely by applicable U.S. laws and governmental regulations. Please see ourPrivacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to ourPrivacy Policy. Your use of the information on this site is subject to the terms of ourLegal Notice. You should view theNewssection and the most recent SEC Filings in theInvestorsection in order to receive the most current information made available by Johnson & Johnson Services, ntact Uswith any questions or search this site for more information.

All contents © Copyright Johnson & Johnson Services, Inc.1997-2019. All Rights Reserved.

You are now leaving . The site youre being redirected to is a branded pharmaceutical website. Please click below to continue to that site.